Award
Delivery Order #36C24526N0606
Delivery Order for TYVASO Medication from United Therapeutics Corporation
Buyer
Department of Veterans Affairs
Award Amount
$33,158.10
Ceiling
$33,158.10
Awarded
May 28, 2026
Period of Performance
May 28, 2026 – Jun 03, 2026
Identifier
36C24526N0606
NAICS
325412
This award represents a delivery order contract with United Therapeutics Corporation, a pharmaceutical company specializing in innovative drugs, including those for pulmonary conditions. The contract involves procuring TYVASO 80 MCG, a medication used to treat pulmonary arterial hypertension, highlighting its significance in supporting critical healthcare needs. The scope covers the timely delivery of this specific pharmaceutical product to a designated location in Memphis, Tennessee, within a concise performance period of approximately one week. This delivery order is issued under a broader Federal Supply Schedule (FSS) contract that United Therapeutics holds with the Department of Veterans Affairs, emphasizing continuity in supplying essential medications to veterans. The contract was awarded through existing agreements, supporting efficient procurement processes without competitive rebidding for this particular order. Key contract milestones include the award and delivery scheduled within late May to early June of 2026.
Description
TYVASO 80 MCG